Neurotransmitter receptor expression and activity during neuronal differentiation of embryonal carcinoma and stem cells: from basic research towards clinical applications.
about
ZNF536, a novel zinc finger protein specifically expressed in the brain, negatively regulates neuron differentiation by repressing retinoic acid-induced gene transcriptionCsn3 gene is regulated by all-trans retinoic acid during neural differentiation in mouse P19 cellsA potent and selective small molecule inhibitor of sirtuin 1 promotes differentiation of pluripotent P19 cells into functional neuronsAscl1/Mash1 is a novel target of Gli2 during Gli2-induced neurogenesis in P19 EC cells.Epigenetic regulation of Dpp6 expression by Dnmt3b and its novel role in the inhibition of RA induced neuronal differentiation of P19 cells.NgR1 Expressed in P19 Embryonal Carcinoma Cells Differentiated by Retinoic Acid Can Activate STAT3.DUSP4 regulates neuronal differentiation and calcium homeostasis by modulating ERK1/2 phosphorylationSynthetic small molecules that induce neuronal differentiation in neuroblastoma and fibroblast cells.Purinergic signalling during development and ageing.Neural responses to electrical stimulation on patterned silk films.Tumor Suppressors and Endodermal Differentiation of P19 Embryonic Stem Cells.New insights into purinergic receptor signaling in neuronal differentiation, neuroprotection, and brain disorders.Cell and gene therapies for refractory epilepsy.RING finger protein 10 regulates retinoic acid-induced neuronal differentiation and the cell cycle exit of P19 embryonic carcinoma cells.Neuronal differentiation involves a shift from glucose oxidation to fermentation.An inducible change in Fox-1/A2BP1 splicing modulates the alternative splicing of downstream neuronal target exons.Neural differentiation of P19 carcinoma cells and primary neurospheres: cell morphology, proliferation, viability, and functionality.D-Serine regulates proliferation and neuronal differentiation of neural stem cells from postnatal mouse forebrain.
P2860
Q24319720-5280DB3D-9674-4B6D-B1D7-8ABACC3C734CQ28592077-FB28F4A1-75A3-47EC-BD28-AA0B8E86C9EEQ28828567-EAEF9492-FAA5-4192-8695-FF341B690EEEQ33895175-B00F38B6-B2DE-4DC0-965B-30A43BAD713EQ34586326-22B21D1B-CFB0-41AF-9200-95554A2B77B4Q35127442-6CEEABA4-4E01-4EA7-9160-CE92AFF76361Q35167139-EB2D468D-10B9-413F-ACAF-0BB568E6519CQ35601109-19770131-53AF-4947-8AC9-80A72616BE40Q35930763-893862C8-4A6F-49B7-8B5B-214FAEEE74F6Q37042980-2DDA15F5-4970-48D7-9BF1-BE12858FE4CAQ37082620-06CDD676-3E9A-4E3A-A1D3-E3270AAAF7D3Q37135526-C01DEDE1-02BF-4960-9A4F-A507B5784EF9Q37211817-71C2875F-D1C7-41A5-8275-584F2C06312AQ39176141-F86221B4-D40A-4BE8-9FC1-4F172E89C83FQ39491909-E87547F9-D956-4F85-BD5F-A4B6F6BA57C3Q39798256-621B87D5-9228-4598-84B8-191EDDFE2998Q48616059-CB5CD97D-8BBA-4AE7-B053-04C3F358645EQ48691271-D15C9094-F842-4660-BCD0-B13EFE04DC55
P2860
Neurotransmitter receptor expression and activity during neuronal differentiation of embryonal carcinoma and stem cells: from basic research towards clinical applications.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Neurotransmitter receptor expr ...... towards clinical applications.
@ast
Neurotransmitter receptor expr ...... towards clinical applications.
@en
type
label
Neurotransmitter receptor expr ...... towards clinical applications.
@ast
Neurotransmitter receptor expr ...... towards clinical applications.
@en
prefLabel
Neurotransmitter receptor expr ...... towards clinical applications.
@ast
Neurotransmitter receptor expr ...... towards clinical applications.
@en
P2860
P1433
P1476
Neurotransmitter receptor expr ...... towards clinical applications.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2184.2006.00385.X
P577
2006-08-01T00:00:00Z